Avidity Partners Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,393,000
| Closed | -$115M | – | 100 |
|
|
2022
Q1 | $115M | Buy |
1,393,000
+586,600
| +73% | +$48.2M | 2.38% | 14 |
|
|
2021
Q4 | $118M | Sell |
806,400
-256,000
| -24% | -$37.6M | 2.51% | 10 |
|
|
2021
Q3 | $188M | Buy |
1,062,400
+309,400
| +41% | +$54.7M | 4.16% | 1 |
|
|
2021
Q2 | $122M | Buy |
753,000
+277,300
| +58% | +$44.8M | 3.29% | 6 |
|
|
2021
Q1 | $81.5M | Buy |
475,700
+95,700
| +25% | +$16.4M | 2.25% | 11 |
|
|
2020
Q4 | $83.5M | Buy |
380,000
+105,000
| +38% | +$23.1M | 2.71% | 10 |
|
|
2020
Q3 | $45.7M | Buy |
+275,000
| New | +$45.7M | 2.12% | 15 |
|
|
2020
Q2 | – | Sell |
-295,000
| Closed | -$22.7M | – | 79 |
|
|
2020
Q1 | $22.7M | Buy |
295,000
+231,000
| +361% | +$17.8M | 3.13% | 8 |
|
|
2019
Q4 | $8.25M | Buy |
+64,000
| New | +$8.25M | 5.2% | 5 |
|